Skip to content

Drug interactions

Larotrectinib + Vardenafil

Severity: Minor

Larotrectinib and Vardenafil: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is mainly a CYP3A4 substrate and has only weak inhibitory potential on CYP3A4, so any rise in vardenafil exposure is likely small. Effects would be mainly increased vasodilatory adverse effects.

What this interaction means in plain words

Larotrectinib and Vardenafil have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Larotrectinib belongs to Oncology; Vardenafil belongs to Genitourinary.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by larotrectinib; the interaction is not well established.

What to do

Monitor blood pressure and tolerability; reduce the vardenafil dose if adverse effects appear.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Larotrectinib and Vardenafil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Larotrectinib with Vardenafil?

MediHelp rates the interaction as minor. Larotrectinib and Vardenafil have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Larotrectinib is mainly a CYP3A4 substrate and has only weak inhibitory potential on CYP3A4, so any rise in vardenafil exposure is likely small. Effects would be mainly increased vasodilatory adverse effects.

How serious is the interaction between Larotrectinib and Vardenafil?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure and tolerability; reduce the vardenafil dose if adverse effects appear.

What other medicines interact with Vardenafil?

MediHelp also lists interactions of Vardenafil with, for example, Amyl nitrite, Glyceryl trinitrate pr, Isosorbide dinitrate. The full list is on the Vardenafil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in